SAVOIA, Paola
 Distribuzione geografica
Continente #
NA - Nord America 1.097
EU - Europa 446
AS - Asia 304
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.851
Nazione #
US - Stati Uniti d'America 1.093
CN - Cina 169
UA - Ucraina 142
IT - Italia 96
DE - Germania 67
SG - Singapore 55
FI - Finlandia 49
HK - Hong Kong 34
FR - Francia 27
GB - Regno Unito 27
IE - Irlanda 23
TR - Turchia 20
IN - India 19
CZ - Repubblica Ceca 6
IR - Iran 5
CA - Canada 4
BE - Belgio 2
PL - Polonia 2
SE - Svezia 2
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
RO - Romania 1
Totale 1.851
Città #
Fairfield 124
Jacksonville 106
Houston 90
Woodbridge 88
Ann Arbor 87
Chandler 82
Ashburn 74
Cambridge 56
Brescia 51
New York 47
Singapore 46
Princeton 44
Wilmington 44
Nanjing 37
Seattle 36
Hong Kong 34
Beijing 33
Helsinki 32
Dearborn 30
Dublin 23
Istanbul 16
Lancaster 11
Nanchang 11
Shanghai 11
Hebei 10
Changsha 9
Des Moines 8
Jiaxing 8
Jinan 8
Kunming 8
Milan 8
San Diego 8
Shenyang 8
Pune 7
Leawood 6
San Mateo 6
Boardman 5
Brno 5
San Donà Di Piave 5
Guangzhou 4
Los Angeles 4
Munich 4
Toronto 4
Verona 4
Ardabil 3
Hangzhou 3
Macerata 3
Ningbo 3
Tianjin 3
Turin 3
Auburn Hills 2
Brussels 2
Chicago 2
Fuzhou 2
Haikou 2
Kocaeli 2
London 2
Norwalk 2
Rho 2
Romola 2
San Francisco 2
San Giovanni in Persiceto 2
Warsaw 2
Zhengzhou 2
Alexandria 1
Augusta 1
Bath 1
Brooklyn 1
Buenos Aires 1
Cagliari 1
Caprino Veronese 1
Changchun 1
Corona 1
Cupertino 1
Frankfurt am Main 1
Fremont 1
Hanover 1
Harbin 1
Hefei 1
Jakarta 1
Leicester 1
Madrid 1
Monmouth Junction 1
Orange 1
Paris 1
Pasadena 1
Phoenix 1
Prague 1
Prescot 1
Sabz 1
Sofia 1
Sydney 1
São Paulo 1
Taiyuan 1
Taizhou 1
Tokyo 1
Totale 1.420
Nome #
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 158
The D3 dopamine receptor: From structural interactions to function. 135
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 126
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 126
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 121
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 116
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 110
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 107
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 76
Role of dopamine D3R/nAChR heterodimeric complex in the regulation of dopaminergic neurons function. 73
D1 receptor signalling in basal ganglia function and dysfunctions. 73
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 72
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 71
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 70
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 70
Down-regulation of the D1R/Shp-2/Erk1/2 pathway ameliorates L-DOPA-induced dyskinesia in the 6-Hydroxy-Dopamine rat model of Parkinson's disease. 68
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 65
Role of dopamine D3R and acetylcholine nicotinic receptor interaction in the regulation of dopaminergic neurons function. 60
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 57
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 55
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 55
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e-Delphi consensus 37
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 22
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis 19
Totale 1.942
Categoria #
all - tutte 9.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.391


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020306 0 0 0 0 19 58 50 49 24 63 19 24
2020/2021278 4 26 4 28 3 30 5 34 41 31 70 2
2021/2022195 21 37 5 2 0 3 13 8 9 27 18 52
2022/2023213 31 0 5 17 22 60 4 21 42 0 7 4
2023/2024234 16 5 21 24 13 70 4 5 37 7 6 26
2024/202595 3 8 2 42 40 0 0 0 0 0 0 0
Totale 1.942